Tanya G K Bentley

Summary

Publications

  1. pmc Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis
    Tanya G K Bentley
    Health Economics and Outcomes Research, Partnership for Health Analytic Research, LLC, 280 S Beverly Drive 404, Beverly Hills, CA 90212 3904, USA
    BMC Res Notes 5:563. 2012
  2. pmc Bias associated with failing to incorporate dependence on event history in Markov models
    Tanya G K Bentley
    RAND Corporation, Santa Monica, CA, USA
    Med Decis Making 30:651-60. 2010
  3. doi request reprint Race and gender associations between obesity and nine health-related quality-of-life measures
    Tanya G K Bentley
    Partnership for Health Analytic Research, LLC, 280 South Beverly Drive 404, Beverly Hills, CA 90212, USA
    Qual Life Res 20:665-74. 2011
  4. doi request reprint Methods for improving efficiency in quality measurement: the example of pain screening
    T G K Bentley
    Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA
    Int J Qual Health Care 23:657-63. 2011
  5. doi request reprint Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches
    Michael S Broder
    Partnership for Health Analytic Research, Beverly Hills, California 90212, USA
    Med Decis Making 32:118-31. 2012
  6. ncbi request reprint Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer
    Burton F Vanderlaan
    Partnership for Health Analytic Research, Beverly Hills, CA 90212, USA
    Am J Manag Care 17:455-64. 2011
  7. ncbi request reprint Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer
    Tanya G K Bentley
    Partnership for Health Analytic Research LLC, Beverly Hills, CA, USA
    J Med Econ 17:527-37. 2014
  8. doi request reprint Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States
    Michael S Broder
    Partnership for Health Analytic Research, Beverly Hills, CA, USA
    J Med Econ 14:167-78. 2011

Detail Information

Publications8

  1. pmc Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis
    Tanya G K Bentley
    Health Economics and Outcomes Research, Partnership for Health Analytic Research, LLC, 280 S Beverly Drive 404, Beverly Hills, CA 90212 3904, USA
    BMC Res Notes 5:563. 2012
    ..This analysis quantifies the impact of varying prevalence rates on test performance for given sensitivity and specificity values...
  2. pmc Bias associated with failing to incorporate dependence on event history in Markov models
    Tanya G K Bentley
    RAND Corporation, Santa Monica, CA, USA
    Med Decis Making 30:651-60. 2010
    ..This analysis assessed the tradeoffs between model bias and complexity when evaluating risks of recurrent events in Markov models...
  3. doi request reprint Race and gender associations between obesity and nine health-related quality-of-life measures
    Tanya G K Bentley
    Partnership for Health Analytic Research, LLC, 280 South Beverly Drive 404, Beverly Hills, CA 90212, USA
    Qual Life Res 20:665-74. 2011
    ..To assess how health-related quality of life (HRQoL) varies by body mass index (BMI) category among gender and racial subgroups using nine HRQoL measures...
  4. doi request reprint Methods for improving efficiency in quality measurement: the example of pain screening
    T G K Bentley
    Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA
    Int J Qual Health Care 23:657-63. 2011
    ..Collecting unnecessary data when assessing quality of care wastes valuable resources. We evaluated three approaches for estimating quality-measure adherence and determined minimum visit data required to achieve accurate estimates...
  5. doi request reprint Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches
    Michael S Broder
    Partnership for Health Analytic Research, Beverly Hills, California 90212, USA
    Med Decis Making 32:118-31. 2012
    ..To develop and validate a claims signature model that estimates proportions of HIV-infected patients in administrative claims databases who switched combination antiretroviral therapy (cART) regimens because of virologic failure...
  6. ncbi request reprint Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer
    Burton F Vanderlaan
    Partnership for Health Analytic Research, Beverly Hills, CA 90212, USA
    Am J Manag Care 17:455-64. 2011
    ..To assess impact on health outcomes and healthcare expenditures of adopting a 21-gene assay for women with early-stage, minimally node-positive, estrogen receptor-positive (N (1-3)/ER) HER2-negative breast cancer...
  7. ncbi request reprint Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer
    Tanya G K Bentley
    Partnership for Health Analytic Research LLC, Beverly Hills, CA, USA
    J Med Econ 17:527-37. 2014
    ..Limitations of this analysis are the lack of data availability and resulting modeling simplifications, although sensitivity analyses showed these to not be key drivers of results. ..
  8. doi request reprint Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States
    Michael S Broder
    Partnership for Health Analytic Research, Beverly Hills, CA, USA
    J Med Econ 14:167-78. 2011
    ..To evaluate lifetime cost effectiveness of atazanavir-ritonavir (ATV + r) versus lopinavir-ritonavir (LPV/r), both with tenofovir-emtricitabine, in US HIV-infected patients initiating first-line antiretroviral therapy...